Pharmafile Logo
Pharmafocus logo
Advanced Search

autoimmune diseases

Showing 7 posts of 7 posts found.

Twist Bioscience and Ono Pharmaceutical enter agreement for discovery of novel antibodies

August 31, 2023
Research and Development Immunology, Ono Pharmaceutical, Twist Bioscience, antibodies, autoimmune diseases

Twist Bioscience has announced that it has entered a drug discovery agreement with Ono Pharmaceutical for the discovery and development …

News
clinical_trials

Kymera Therapeutics reports positive data in cancer drug trials

June 14, 2023
Research and Development Cancer, Kymera Therapeutics, Oncology, autoimmune diseases, clinical trials, inflammatory diseases

US clinical-stage biopharmaceutical company Kymera Therapeutics has shared new data regarding its oncology programmes KT-333 and KT-413, highlighting their robust dose-dependent …

News

Scipher Medicine to expand into autoimmune disease therapeutics

April 30, 2021
Medical Communications AI, autoimmune diseases

Scipher Medicine, a precision immunology company, announced the launch on Scipher Therapeutics on Thursday, marking the company’s shift towards the …

News
gsk_l_rgb

Interview: GSK’s subcutaneous formulation for Benlysta may help cut down hospital visits

June 22, 2016
Research and Development Benlysta, EULAR, Interview, Lupus, NICE, autoimmune diseases, drug trial

UK drugmaker GlaxoSmithKine (LSE: GSK) reported positive results for Benlysta following a late-stage study at the annual European Congress of …

Feature
Merck/MSD

MSD chooses partner to develop ‘game-changing’ cancer therapies

January 6, 2016
Research and Development CPABs, Cancer, Cell-Penetrating Alphabodies, Complix, MSD, autoimmune diseases

MSD has entered a research collaboration with biopharma company Complix, using the company’s proprietary technology to develop new treatments for …

News
Eli Lilly & Company

Lilly prepares late-stage pipeline boost

July 1, 2011
Research and Development, Sales and Marketing autoimmune diseases, diabetes, lilly, neuroscience, oncology

Eli Lilly has highlighted diabetes, oncology, autoimmune diseases and neuroscience as key therapy areas within its growth strategy. Within these …

News
GSK's UK headquarters

GSK signs £64m autoimmune antibody deal

January 7, 2011
Research and Development GSK, GlaxoSmithKline, ImmuTune IMP731, Immutep, autoimmune diseases

GlaxoSmithKline has signed a worldwide licence agreement for a novel antibody designed to treat autoimmune diseases.The company will pay up …

News

Latest content

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023

FDA grants breakthrough device designation to Inflammatix’s TriVerity Acute Infection and Sepsis Test System

November 29, 2023

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023

Arcturus Therapeutics gains FDA ODD for cystic fibrosis treatment

November 28, 2023

Sanofi and Regeneron share results from phase 3 trial for Dupixent as COPD treatment

November 27, 2023